ATP-gated P2X7 receptor as a potential target for prostate cancer.

IF 3.1 3区 生物学 Human Cell Pub Date : 2022-09-01 Epub Date: 2022-06-03 DOI:10.1007/s13577-022-00729-x
Cuicui Qiao, Yiqing Tang, Qianqian Li, Xiaodi Zhu, Xiaoxiang Peng, Ronglan Zhao
{"title":"ATP-gated P2X7 receptor as a potential target for prostate cancer.","authors":"Cuicui Qiao, Yiqing Tang, Qianqian Li, Xiaodi Zhu, Xiaoxiang Peng, Ronglan Zhao","doi":"10.1007/s13577-022-00729-x","DOIUrl":null,"url":null,"abstract":"<p><p>Prostate cancer is the most common malignancy of the male genitourinary system and is one of the leading causes of male cancer death. The P2X7 receptor is an important member of purine receptor family. It is a gated ion channel with adenosine triphosphate (ATP) as the ligand, which exists in a variety of immune tissues and cells and can be involved in tumorigenesis and tumor progression. Studies have shown that the P2X7 receptor is abnormally expressed in prostate cancer, and is related to the level of prostate-specific antigen, P2X7 receptor may be an early biomarker of prostate cancer. The P2X7 receptor is essential in the occurrence and development of prostate cancer. The P2X7 receptor mainly affects the invasion and metastasis of prostate cancer cells through epithelial mesenchymal transition/invasion-related genes and the PI3K/AKT and ERK1/2 signaling pathways. The P2X7 receptor could be a promising therapeutic target for prostate cancer.</p>","PeriodicalId":13228,"journal":{"name":"Human Cell","volume":"35 1","pages":"1346-1354"},"PeriodicalIF":3.1000,"publicationDate":"2022-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Human Cell","FirstCategoryId":"99","ListUrlMain":"https://doi.org/10.1007/s13577-022-00729-x","RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2022/6/3 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Prostate cancer is the most common malignancy of the male genitourinary system and is one of the leading causes of male cancer death. The P2X7 receptor is an important member of purine receptor family. It is a gated ion channel with adenosine triphosphate (ATP) as the ligand, which exists in a variety of immune tissues and cells and can be involved in tumorigenesis and tumor progression. Studies have shown that the P2X7 receptor is abnormally expressed in prostate cancer, and is related to the level of prostate-specific antigen, P2X7 receptor may be an early biomarker of prostate cancer. The P2X7 receptor is essential in the occurrence and development of prostate cancer. The P2X7 receptor mainly affects the invasion and metastasis of prostate cancer cells through epithelial mesenchymal transition/invasion-related genes and the PI3K/AKT and ERK1/2 signaling pathways. The P2X7 receptor could be a promising therapeutic target for prostate cancer.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
atp门控P2X7受体作为前列腺癌的潜在靶点
前列腺癌是男性泌尿生殖系统最常见的恶性肿瘤,也是男性癌症死亡的主要原因之一。P2X7受体是嘌呤受体家族的重要成员。它是以三磷酸腺苷(adenosine triphosphate, ATP)为配体的门控离子通道,存在于多种免疫组织和细胞中,参与肿瘤的发生和进展。研究表明,P2X7受体在前列腺癌中异常表达,且与前列腺特异性抗原水平有关,P2X7受体可能是前列腺癌的早期生物标志物。P2X7受体在前列腺癌的发生和发展中是必不可少的。P2X7受体主要通过上皮间质转移/侵袭相关基因和PI3K/AKT、ERK1/2信号通路影响前列腺癌细胞的侵袭转移。P2X7受体可能是前列腺癌的一个有希望的治疗靶点。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Human Cell
Human Cell 生物-细胞生物学
CiteScore
6.60
自引率
2.30%
发文量
176
期刊介绍: Human Cell is the official English-language journal of the Japan Human Cell Society. The journal serves as a forum for international research on all aspects of the human cell, encompassing not only cell biology but also pathology, cytology, and oncology, including clinical oncology. Embryonic stem cells derived from animals, regenerative medicine using animal cells, and experimental animal models with implications for human diseases are covered as well. Submissions in any of the following categories will be considered: Research Articles, Cell Lines, Rapid Communications, Reviews, and Letters to the Editor. A brief clinical case report focusing on cellular responses to pathological insults in human studies may also be submitted as a Letter to the Editor in a concise and short format. Not only basic scientists but also gynecologists, oncologists, and other clinical scientists are welcome to submit work expressing new ideas or research using human cells.
期刊最新文献
PROX1 is a regulator of neuroendocrine-related gene expression in lung carcinoid Establishment and characterization of TK-ALCL1: a novel NPM-ALK-positive anaplastic large-cell lymphoma cell line. Overexpressing Bcl-2 enhances murine chimeric antigen receptor T cell therapy against solid tumor MicroRNA-322-5p targeting Smurf2 regulates the TGF-β/Smad pathway to protect cardiac function and inhibit myocardial infarction. Genetic diversity among the present Japanese population: evidence from genotyping of human cell lines established in Japan.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1